- Home
- ENB vs GSK Comparison
ENB vs GSK Comparison
Compare ENB & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENB
- GSK
- Stock Information
- Founded
- ENB 1949
- GSK 1715
- Country
- ENB Canada
- GSK United Kingdom
- Employees
- ENB N/A
- GSK N/A
- Industry
- ENB Natural Gas Distribution
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- ENB Energy
- GSK Health Care
- Exchange
- ENB Nasdaq
- GSK Nasdaq
- Market Cap
- ENB N/A
- GSK 79.8B
- IPO Year
- ENB N/A
- GSK N/A
- Fundamental
- Price
- ENB $41.84
- GSK $38.97
- Analyst Decision
- ENB Sell
- GSK Buy
- Analyst Count
- ENB 2
- GSK 5
- Target Price
- ENB $48.00
- GSK $48.00
- AVG Volume (30 Days)
- ENB 2.6M
- GSK 5.1M
- Earning Date
- ENB 11-01-2024
- GSK 10-30-2024
- Dividend Yield
- ENB 6.38%
- GSK 4.03%
- EPS Growth
- ENB 39.57
- GSK N/A
- EPS
- ENB 1.91
- GSK 1.24
- Revenue
- ENB $31,794,834,330.00
- GSK $39,741,175,591.00
- Revenue This Year
- ENB N/A
- GSK $7.41
- Revenue Next Year
- ENB N/A
- GSK $5.65
- P/E Ratio
- ENB $21.90
- GSK $15.58
- Revenue Growth
- ENB N/A
- GSK 7.20
- 52 Week Low
- ENB $31.31
- GSK $33.67
- 52 Week High
- ENB $42.03
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- ENB 68.02
- GSK 41.38
- Support Level
- ENB $40.72
- GSK $38.82
- Resistance Level
- ENB $41.10
- GSK $39.40
- Average True Range (ATR)
- ENB 0.48
- GSK 0.80
- MACD
- ENB 0.04
- GSK 0.01
- Stochastic Oscillator
- ENB 88.96
- GSK 29.13
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.